Propanc Biopharma, Inc. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported net loss was USD 0.350866 million compared to USD 0.617295 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 2.13 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | -9.09% | -9.09% | -91.67% |
1st Jan change | Capi. | |
---|---|---|
-91.67% | 119K | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PPCB Stock
- News Propanc Biopharma, Inc.
- Propanc Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023